MIQE challenges and solutions: The use of-omics technologies for transcriptional biomarker discovery

Michael W Pfaffl
2015-10-01
Abstract:Quantitative real-time RT-PCR (RT-qPCR) is the ‘Gold standard’in molecular diagnostics. Hence it is widely and increasingly used because of its high sensitivity, good reproducibility, and wide dynamic quantification range. RT-qPCR is the most sensitive method for the detection and quantification of mRNA and microRNA expression levels, in particular for low abundant transcripts in tissues with low RNA concentrations, eg in single-cells isolated from the circulation. While RT-qPCR has a tremendous potential for analytical and quantitative applications, a comprehensive understanding of its underlying quantification strategy is important, and how to optimise and validate the quantification workflow to reduce noise.The first part of the talk will cover practical considerations with focus on RT-qPCR optimisation and standardisation according to the MIQE guidelines; in particular RNA integrity, PCR efficiency correction and normalisation using reference genes. The second part focuses on the discovery of ‘Transcriptional Biomarkers’. Biomarkers have been used extensively across diagnostic and therapeutic areas over many life science disciplines. Herein we developed and validate ‘transcribed biomarker signatures’ for the detection of drug abuse, to guarantee wholesome food. Gene expression is a dynamic process that adapts very fast to physiological changes or exogenous stimuli and thus the transcriptome with its enormous number of alternative spliced RNAs reflects the current physiological status. Therefore monitoring the transcriptome is a potential and very promising way for detecting biomarkers for specific physiological situations, diseases or …
What problem does this paper attempt to address?